WCG IPO Presentation Deck

Case Study: Centralized Global Vaccine Trial Huw 24 Large Biopharma Case Study: WCG Enrolled Over 32,000 of 44,000 Patients WCG's Support Resulted in 42% Patient Diversity . WCG played a crucial role in enrolling over 32,000 patients into Client's COVID-19 vaccine program . WCG supported Client in achieving 42% participant diversity in their COVID-19 trial "There is no way that we could have achieved our enrollment targets without WCG on our vaccine program... Because of WCG's success in our COVID vaccine program, we are asking ourselves why wouldn't we want that same performance for all vaccine trials going forward - COVID or otherwise?" Large Biopharma Global Clinical Trial Executive ONJEL wcg

View entire presentation